Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NICE issues positive final appraisal determination of Acomplia for obesity

March 31, 2008

Recent Leo patent describes new therapeutic options for hyperparathyroidism

March 31, 2008

Novel GnRH allosteric modulator discovered at Organon

March 28, 2008

Preclinical profile of Wyeth's novel progesterone receptor modulator

March 28, 2008

First Committee on New Drugs passes AnGes' NDA for Naglazyme for MPS VI

March 27, 2008

Thyroid-stimulating hormone reverses ovariectomy-induced bone loss in rats

March 27, 2008

Acceleron and Celgene receive Hart-Scott-Rodino clearance for ACE-011 collaboration

March 27, 2008

Pivotal diabetes study of mitiglinide completes enrollment

March 27, 2008

Recent Biovitrum patent describes novel antiobesity agents

March 27, 2008

DiaMedica enrolls first patient in phase II human clinical trial for DM-83

March 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...